Herpes simplex virus type 1 and human DNA polymerase interactions with 2'-deoxyguanosine 5'-triphosphate analogues. Kinetics of incorporation into DNA and induction of inhibition
about
Pyrophosphorolytic Excision of Nonobligate Chain Terminators by Hepatitis C Virus NS5B PolymerasePhosphonoformic Acid Inhibits Viral Replication by Trapping the Closed Form of the DNA PolymeraseMechanism of ganciclovir-induced chain termination revealed by resistant viral polymerase mutants with reduced exonuclease activityEffects of (-)-2'-deoxy-3'-thiacytidine (3TC) 5'-triphosphate on human immunodeficiency virus reverse transcriptase and mammalian DNA polymerases alpha, beta, and gammaMode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virusEffect of incorporation of cidofovir into DNA by human cytomegalovirus DNA polymerase on DNA elongationCharacterization of herpes simplex virus type 1 thymidine kinase mutants engineered for improved ganciclovir or acyclovir activity.Inhibition of B virus (Macacine herpesvirus 1) by conventional and experimental antiviral compounds.Fusion enzymes containing HSV-1 thymidine kinase mutants and guanylate kinase enhance prodrug sensitivity in vitro and in vivo.Herpes simplex virus DNA packaging without measurable DNA synthesis.Antiviral activities of oral 1-O-hexadecylpropanediol-3-phosphoacyclovir and acyclovir in woodchucks with chronic woodchuck hepatitis virus infectionInduction of Epstein-Barr virus kinases to sensitize tumor cells to nucleoside analoguesA biobrick library for cloning custom eukaryotic plasmids.Conditional depletion of neurogenesis inhibits long-term recovery after experimental stroke in mice.Alteration of the carbohydrate for deoxyguanosine analogs markedly changes DNA replication fidelity, cell cycle progression and cytotoxicityDifferential mutation patterns in thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 clones passaged in the presence of acyclovir or penciclovir.Consistent inhibition of HIV-1 replication in CD4+ T cells by acyclovir without detection of human herpesviruses.Stem cells as vectors to deliver HSV/tk gene therapy for malignant gliomasIdentification of the lytic origin of DNA replication in human cytomegalovirus by a novel approach utilizing ganciclovir-induced chain termination.The antiherpetic drug acyclovir inhibits HIV replication and selects the V75I reverse transcriptase multidrug resistance mutationEngineering of a chimeric RB69 DNA polymerase sensitive to drugs targeting the cytomegalovirus enzyme.Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy.Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis.Herpes simplex virus type 1 prereplicative sites are a heterogeneous population: only a subset are likely to be precursors to replication compartments.Priming of duck hepatitis B virus reverse transcription in vitro: premature termination of primer DNA induced by the 5'-triphosphate of fialuridine.Intranuclear accumulation of subgenomic noninfectious human cytomegalovirus DNA in infected cells in the presence of ganciclovir.Potency and Stereoselectivity of Cyclopropavir Triphosphate Action on Human Cytomegalovirus DNA Polymerase.
P2860
Q27480921-8F6CC1B7-E79E-44AE-92F2-52D30727AAA6Q27667828-CF2B991A-3D92-49B8-9088-AFBDCC027429Q28252113-B5AF206B-19EC-4ADD-86C7-DDF7C6D55C62Q28316436-190AFFF7-FD44-46E3-A592-4180474C3666Q28327167-28979741-53F9-4692-AB54-3DB634C41F43Q28379498-37122204-929B-49FB-847C-8312927CE171Q33184179-1259E8D0-1DFA-4F78-911A-43648EC0CFADQ33558962-29B7035D-87D0-48B9-B2D4-0ADD231880BDQ33598652-B6C9F0E6-F001-43CF-AF46-DA4713118041Q33783013-0037E478-6620-4808-8487-25D612022273Q33980098-47DB3A71-EF27-4B67-AD0B-876B5669CFF9Q33982537-E76D0390-352D-4FE7-988C-AC430D39BF28Q34013721-B7C9C3DD-3C16-4CE1-9713-5A824265A33FQ34314022-A24C1823-BE7D-4C5C-AA5A-D18A36D31715Q34572161-5B4CA946-AE57-45EF-BC7D-530A998B1AF3Q34938781-B3629609-6C6C-48D0-9067-2B2872DA2219Q35076929-618F8227-504C-4E2E-A365-46823EBC5255Q36062517-0A090E1F-7750-4E02-B7A9-A04ACD944563Q36796269-339F1A84-4861-4D2D-A817-88DC3C616F59Q36968375-2EC1B65B-8FD4-497A-9342-141E9D9B5439Q37446675-795E0E54-41DA-4C32-8F7A-7579BCF99E81Q37660477-6B4B8A11-B5CF-4F1A-AE8D-0B7C053321F8Q39867349-F504BB66-6853-476C-B908-90D8D30A8050Q39880009-75C894D3-28D4-45F6-8162-48282AF2B5BFQ40043127-2A4FA8C1-6BB5-4FC8-B26F-EAAE8CA0562EQ40087350-075E931E-3611-4C77-93E3-E1BA7D2B8BB3Q40771642-27AF9426-3A99-44A9-9703-990F6D3E980E
P2860
Herpes simplex virus type 1 and human DNA polymerase interactions with 2'-deoxyguanosine 5'-triphosphate analogues. Kinetics of incorporation into DNA and induction of inhibition
description
1989 nî lūn-bûn
@nan
1989 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Herpes simplex virus type 1 an ...... NA and induction of inhibition
@ast
Herpes simplex virus type 1 an ...... NA and induction of inhibition
@en
Herpes simplex virus type 1 an ...... NA and induction of inhibition
@nl
type
label
Herpes simplex virus type 1 an ...... NA and induction of inhibition
@ast
Herpes simplex virus type 1 an ...... NA and induction of inhibition
@en
Herpes simplex virus type 1 an ...... NA and induction of inhibition
@nl
prefLabel
Herpes simplex virus type 1 an ...... NA and induction of inhibition
@ast
Herpes simplex virus type 1 an ...... NA and induction of inhibition
@en
Herpes simplex virus type 1 an ...... NA and induction of inhibition
@nl
P1476
Herpes simplex virus type 1 an ...... NA and induction of inhibition
@en
P2093
J E Reardon
P304
P407
P577
1989-11-15T00:00:00Z